21. PCSK9 deficiency and heart metabolism. (August 2021) Authors: Da Dalt, L.; Castiglioni, L.; Baragetti, A.; Pellegatta, F.; Svecla, M.; Sironi, L.; Mitro, N.; Catapano, A.L.; Norata, D.G. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. PCSK9 deficiency results in altered glucose control and increased ectopic fat accumulation in experimental models and in humans. (August 2018) Authors: Baragetti, A.; Grejtakova, D.; Zampoleri, V.; Uboldi, P.; Garlaschelli, K.; Balzarotti, G.; Grigore, L.; Pellegatta, F.; Guerrini, U.; Pisano, G.; Fracanzani, A.L.; Fargion, S.; Norata, G.D.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. PCSK9 modulates cardiac metabolism and impacts HFpEF. (August 2022) Authors: Da Dalt, L.; Castiglioni, L.; Baragetti, A.; Audano, M.; Svecla, M.; Bonacina, F.; Pedretti, S.; Uboldi, P.; Benzoni, P.; Giannetti, F.; Barbuti, A.; Pellegatta, F.; Indino, S.L.; Donetti, E.; Sironi, L.; Mitro, N.; Catapano, A.L.; Norata, G.D. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Pcsk9 Mutations: Effects Beyond Ldl Cholesterol. (August 2019) Authors: Zampoleri, V.; Casula, M.; Gazzotti, M.; Baragetti, A.; Pellegatta, F.; Grigore, L.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Pentraxin 3 Plays A Key Role In The Immunomodulation Of Diet Induced-Obesity In Mice. (August 2019) Authors: Moregola, A.; Bonacina, F.; Baragetti, A.; Porte, R.; Sironi, M.; Grigore, L.; Pellegatta, F.; Bottazzi, B.; Garlanda, C.; Mantovani, A.; Catapano, A.L.; Norata, G.D. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Post-Prandial Lipemia And Cd36. (August 2019) Authors: Zampoleri, V.; Baragetti, A.; Bonacina, F.; Pedretti, S.; Grigore, L.; Pellegatta, F.; Redaelli, L.; Mitro, N.; Norata, D.G.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies. (August 2021) Authors: Alieva, A.; Olmastroni, E.; Reutova, O.; Rotar, O.; Konradi, A.; Baragetti, A.; Grigore, L.; Pellegatta, F.; Casula, M.; Tragni, E.; Shlyakhto, E.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. (19th July 2014) Authors: Baragetti, A.; Palmen, J.; Garlaschelli, K.; Grigore, L.; Pellegatta, F.; Tragni, E.; Catapano, A. L.; Humphries, S. E.; Norata, G. D.; Talmud, P. J. Journal: Journal of internal medicine Issue: Volume 277:Number 4(2015:Apr.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. The long pentraxin 3 (PTX3) plays a key role in the immunomodulation of diet induced-obesity in mice. (August 2018) Authors: Bonacina, F.; Moregola, A.; Baragetti, A.; Bonavita, E.; Garlaschelli, K.; Salatin, A.; Grigore, L.; Pellegatta, F.; Garlanda, C.; Bottazzi, B.; Mantovani, A.; Catapano, A.L.; Norata, G.D. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. The low density lipoprotein receptor (LDLR) is crucial for the activation of CD8+ TCELLS. (December 2020) Authors: Bonacina, F.; Moregola, A.; Coe, D.; Pellegatta, F.; Catapano, A.L.; Marelli-Berg, F.; Norata, D.G. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗